Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Can't get enough of that dopamine.

Cohen BM, Carlezon WA Jr.

Am J Psychiatry. 2007 Apr;164(4):543-6. No abstract available.

PMID:
17403963
2.

Cocaine reward and dopamine receptors: love at first site.

Koob GF.

Arch Gen Psychiatry. 1999 Dec;56(12):1107-8. No abstract available.

PMID:
10591287
3.

A mechanism for the involvement of colocalized neuropeptides in the actions of antipsychotic drugs.

Gariano RF, Groves PM.

Biol Psychiatry. 1989 Jul;26(3):303-14. Review.

PMID:
2568135
4.

Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166)

Romach MK, Glue P, Kampman K, Kaplan HL, Somer GR, Poole S, Clarke L, Coffin V, Cornish J, O'Brien CP, Sellers EM.

Arch Gen Psychiatry. 1999 Dec;56(12):1101-6.

PMID:
10591286
5.

Recent finding on dopaminergic transmission in the basal ganglia.

Glowinski J.

Adv Neurol. 1990;53:67-73. Review. No abstract available.

PMID:
2173377
7.

Anatomy and pharmacology of cocaine priming-induced reinstatement of drug seeking.

Schmidt HD, Anderson SM, Famous KR, Kumaresan V, Pierce RC.

Eur J Pharmacol. 2005 Dec 5;526(1-3):65-76. Review.

PMID:
16321382
8.

Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems.

Shippenberg TS, Chefer VI, Zapata A, Heidbreder CA.

Ann N Y Acad Sci. 2001 Jun;937:50-73. Review.

PMID:
11458540
9.

Physiology of the normal and dopamine-depleted basal ganglia: insights into levodopa pharmacotherapy.

Grace AA.

Mov Disord. 2008;23 Suppl 3:S560-9. doi: 10.1002/mds.22020. Review.

PMID:
18781673
10.

Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.

Moran-Gates T, Massari C, Graulich A, LiƩgeois JF, Tarazi FI.

J Neurosci Res. 2006 Aug 15;84(3):675-82.

PMID:
16810690
11.

Drug-induced movement disorders.

Gershanik OS.

Curr Opin Neurol Neurosurg. 1993 Jun;6(3):369-76. Review.

PMID:
8099509
12.
13.

Pharmacological approaches to cocaine addiction.

Dackis CA, Gold MS.

J Subst Abuse Treat. 1985;2(3):139-45. Review.

PMID:
3912517
14.

Neuroleptics and psychic indifference: a review.

Healy D.

J R Soc Med. 1989 Oct;82(10):615-9. Review. No abstract available.

15.
16.

Central stimulant abuse: neurochemistry and pharmacotherapy.

Dackis CA, Gold MS, Pottash AL.

Adv Alcohol Subst Abuse. 1986 Winter;6(2):7-21.

PMID:
2886014
17.

Neuroleptic reduction of cocaine-induced paranoia but not euphoria?

Gawin FH.

Psychopharmacology (Berl). 1986;90(1):142-3.

PMID:
2876452
18.

Are movement disorders the most serious side effects of maintenance therapy with antipsychotic drugs?

Lidsky TI, Labuszewski T, Levine FM.

Biol Psychiatry. 1981 Dec;16(12):1189-94.

PMID:
6130799
19.

Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs.

Baldessarini RJ, Tarsy D.

Annu Rev Neurosci. 1980;3:23-41. Review. No abstract available.

PMID:
6106450
20.

Effects of cholecystokinin antagonists on the discriminative stimulus effects of cocaine in rats and monkeys.

Massey BW, Vanover KE, Woolverton WL.

Drug Alcohol Depend. 1994 Jan;34(2):105-11.

PMID:
8026297

Supplemental Content

Support Center